ClinicalTrials.govpublic full text
Trial of Patidegib Gel 2%, 4%, and Vehicle to Decrease the Number of Surgically Eligible Basal Cell Carcinomas in Gorlin Syndrome Patients
basal cell nevus syndrome, gorlin syndrome, basal cell, nevus syndrome, bcns, nevoid basal cell carcinoma syndrome, basal cell carcinoma, hedgehog, surgically eligible basal cell carcinomas, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 910520
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.